United Therapeutics Corporation Appoints Victor Dzau to Board of Directors
United Therapeutics Corporation has appointed Victor Dzau, M.D., to its Board of Directors, effective July 22, 2026. Dr. Dzau has extensive experience, having recently concluded a 12-year tenure as President of the National Academy of Medicine and held various leadership roles at Duke University and its Health System.
SILVER SPRING, Md. & DURHAM, N.C.–(BUSINESS WIRE)–United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that the company’s Board of Directors appointed Victor Dzau, M.D., to its Board on July 22, 2026.Dr. Dzau recently completed a 12-year tenure as President of the National Academy of Medicine (NAM) and formerly served as Chancellor for Health Affairs at Duke University, President and CEO of the Duke University Health System, and Chairman of Medicine at